 Patients receive paclitaxel albumin-stabilized nanoparticle formulation ABI-007; Abraxane IV over 30 minutes on days 1, 8, and 15 and bevacizumab IV over 30-90 minutes on days 1 and 15. Treatment repeats every 28 days in the absence of disease progression or unacceptable toxicity. 